Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Paula Martinez Sanz; Dieke J. van Rees; Hanke L. Matlung; Godelieve A. M. Tytgat; Katka Franke

doi:https://doi.org/10.1136/jitc-2021-003983

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Paula Martinez Sanz, Dieke J. van Rees, Hanke L. Matlung, Godelieve A. M. Tytgat, Katka Franke

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Original language	English
Article number	e003983
Journal	Journal for Immunotherapy of Cancer
Volume	9
Issue number	12
DOIs	https://doi.org/10.1136/jitc-2021-003983
Publication status	Published - 1 Dec 2021

Access to Document

https://doi.org/10.1136/jitc-2021-003983

Cite this

@article{f50611b6364b44dcb565dbd0889ea58f,

title = "Response to: Correspondence on {"}g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment{"} by Mora et al",

author = "{Martinez Sanz}, Paula and {van Rees}, {Dieke J.} and Matlung, {Hanke L.} and Tytgat, {Godelieve A. M.} and Katka Franke",

year = "2021",

month = dec,

day = "1",

doi = "https://doi.org/10.1136/jitc-2021-003983",

language = "English",

volume = "9",

journal = "Journal for Immunotherapy of Cancer",

issn = "2051-1426",

publisher = "BioMed Central",

number = "12",

}

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al. / Martinez Sanz, Paula; van Rees, Dieke J.; Matlung, Hanke L. et al.
In: Journal for Immunotherapy of Cancer, Vol. 9, No. 12, e003983, 01.12.2021.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Response to

T2 - Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

AU - Martinez Sanz, Paula

AU - van Rees, Dieke J.

AU - Matlung, Hanke L.

AU - Tytgat, Godelieve A. M.

AU - Franke, Katka

PY - 2021/12/1

Y1 - 2021/12/1

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122483698&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/34893526

U2 - https://doi.org/10.1136/jitc-2021-003983

DO - https://doi.org/10.1136/jitc-2021-003983

M3 - Comment/Letter to the editor

C2 - 34893526

SN - 2051-1426

VL - 9

JO - Journal for Immunotherapy of Cancer

JF - Journal for Immunotherapy of Cancer

IS - 12

M1 - e003983

ER -

Response to: Correspondence on "g-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Access to Document

Other files and links

Cite this